The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.
|Original language||English (US)|
|Number of pages||4|
|Journal||American Journal of Managed Care|
|State||Published - Dec 1 1996|
ASJC Scopus subject areas
- Health Policy